Condition: Pulmonary Sarcoidosis · Sponsor: Xentria, Inc.
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
This description comes directly from the study's public registry record.
Xentria, Inc. · 224-443-4615 · contact@xentria.com
Always discuss trial participation with your own doctor first.
| Xentria Investigative Site | Birmingham, Alabama, United States | Recruiting |
| Xentria Investigative Site | Denver, Colorado, United States | Recruiting |
| Xentria Investigative Site | Jacksonville, Florida, United States | Completed |
| Xentria Investigative Site | Chicago, Illinois, United States | Recruiting |
| Xentria Investigative Site | Chicago, Illinois, United States | Recruiting |
| Xentria Investigative Site | Iowa City, Iowa, United States | Recruiting |
| Xentria Investigative Site | Baltimore, Maryland, United States | Recruiting |
| Xentria Investigative Site | Detroit, Michigan, United States | Recruiting |
| Xentria Investigative Site | Minneapolis, Minnesota, United States | Recruiting |
| Xentria Investigative Site | Albany, New York, United States | Terminated |
| Xentria Investigative Site | New York, New York, United States | Recruiting |
| Xentria Investigative Site | Greenville, North Carolina, United States | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05890729